ReproCell Inc
TSE:4978
ReproCell Inc
TSE:4978
Price:
136 JPY
3.03%
Market Closed
Updated:
May 15, 2024
ReproCell Inc
Operating Expenses
|
ReproCell Inc
Operating Expenses Peer Comparison
Comparables:
2160
4587
4974
2929
S
4599
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
ReproCell Inc
TSE:4978
|
Operating Expenses
-¥1.5B
|
CAGR 3-Years
3%
|
CAGR 5-Years
10%
|
CAGR 10-Years
-17%
|
|
|
GNI Group Ltd
TSE:2160
|
Operating Expenses
-¥17.3B
|
CAGR 3-Years
-38%
|
CAGR 5-Years
-37%
|
CAGR 10-Years
-36%
|
|
|
PeptiDream Inc
TSE:4587
|
Operating Expenses
-¥10.4B
|
CAGR 3-Years
-60%
|
CAGR 5-Years
-47%
|
CAGR 10-Years
N/A
|
|
|
Takara Bio Inc
TSE:4974
|
Operating Expenses
-¥24.9B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-9%
|
|
|
Pharma Foods International Co Ltd
TSE:2929
|
Operating Expenses
-¥46B
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-47%
|
CAGR 10-Years
-49%
|
|
S
|
StemRIM Inc
TSE:4599
|
Operating Expenses
-¥2.2B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-31%
|
CAGR 10-Years
N/A
|
See Also
What is ReproCell Inc's Operating Expenses?
Operating Expenses
-1.5B
JPY
-1.5B
JPY
Based on the financial report for Dec 31, 2023, ReproCell Inc's Operating Expenses amounts to -1.5B JPY.
What is ReproCell Inc's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-17%
-17%
Over the last year, the Operating Expenses growth was -3%. The average annual Operating Expenses growth rates for ReproCell Inc have been 3% over the past three years , 10% over the past five years , and -17% over the past ten years .
You don't have any saved screeners yet
